FILTER
FILTERED INTERVIEW RESULTS
Andrew van Zyl
DIRECTOR, SRK CONSULTING (SA)
SRK Consulting is an international consultancy service provider for the natural resource industry, operating in South Africa, DRC and Ghana.
Ralf Hennecke
GENERAL MANAGER: TECHNOLOGY AND MARKETING, BME
BME offers products and services including explosives, bulk emulsions, initiating systems, technical services and software for surface and underground mining.
Enoch Kusi-Yeboah
GENERAL MANAGER, METSO MINERALS GHANA
From its offices in Ghana, Metso comments on how its offering is developing alongside the West African mining industry.
Kouamé Klemet-N’Guessan
PARTNER, KSK AVOCATS
KSK Avocats, a leading law firm in Côte d’Ivoire involved in the mining industry, explains the regulations related to operating in the country.
Raphael Khalifa
FOUNDER, TEMBO POWER
Tembo Power is developing hydropower projects across Africa with a focus on DRC.
Fanon Beya
COMPANY DIRECTOR, CONNEXAFRICA
After cementing its position as a logistics industry leader in the DRC for over six decades, Comexas Afrique is launching into a new phase of existence and undergoing a rebrand, which will introduce the world to a new name, ConnexAfrica.
Federico De Simone
CHAIRMAN, DE SIMONE GROUP
De Simone is a Ghanaian indigenous company that started operating in 1964 and has since expanded into various sectors such as power, mining and oil & gas, and currently operates in Ghana, Ivory Coast, Burkina Faso, Nigeria, Liberia, Mali and Guinea.
Caigen Wang
CEO, TIETTO MINERALS
Tietto Minerals outlines developments at its Abujar gold project in Ivory Coast.
Eric Asubonteng
MANAGING DIRECTOR, ANGLOGOLD ASHANTI
AngloGold Ashanti speaks about its Obuasi mine in Ghana.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
